AG
Artal Group Portfolio holdings
AUM
$930M
This Quarter Return
+21.99%
1 Year Return
-3.57%
3 Year Return
+157.23%
5 Year Return
+160.22%
10 Year Return
+1,359.85%
AUM
$6.8B
AUM Growth
+$6.8B
(+27%)
Cap. Flow
+$226M
Cap. Flow
% of AUM
3.33%
Top 10 Holdings %
Top 10 Hldgs %
92.21%
Holding
134
New
22
Increased
25
Reduced
13
Closed
23
Top Buys
| 1 |
ONC
BeOne Medicines Ltd. American Depositary Shares
ONC
|
$50.4M |
| 2 |
BPMC
Blueprint Medicines
BPMC
|
$32.1M |
| 3 |
Nektar Therapeutics
NKTR
|
$31.9M |
| 4 |
TSRO
TESARO, Inc.
TSRO
|
$28.6M |
| 5 |
Amicus Therapeutics
FOLD
|
$22.6M |
Top Sells
| 1 |
Neurocrine Biosciences
NBIX
|
$19.4M |
| 2 |
Incyte
INCY
|
$16.7M |
| 3 |
GBT
Global Blood Therapeutics, Inc.
GBT
|
$7.25M |
| 4 |
CLVS
Clovis Oncology, Inc.
CLVS
|
$6.8M |
| 5 |
ALDR
Alder Biopharmaceuticals, Inc.
ALDR
|
$5.73M |
Sector Composition
| 1 | Consumer Staples | 51.19% |
| 2 | Consumer Discretionary | 27.58% |
| 3 | Healthcare | 20.59% |
| 4 | Communication Services | 0.17% |
| 5 | Materials | 0.06% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
BUFF
1
DELISTED
Blue Buffalo Pet Products, Inc
BUFF
| $3.48B | 43.57% | 87,460,875 | – | – |
|
|
WW
2
DELISTED
WW International
WW
| $1.88B | 23.48% | 29,443,300 | – | – |
|
3
Lexicon Pharmaceuticals
LXRX
$400M
| $499M | 6.25% | 58,274,650 | – | – |
|
|
ONC
4
BeOne Medicines Ltd. American Depositary Shares
ONC
$36.4B
| $101M | 1.26% | 600,000 +300,000 | +100% | +$50.4M |
|
|
5
Nektar Therapeutics
NKTR
$568M
| $74.4M | 0.93% | 700,000 +300,000 | +75% | +$31.9M |
|
6
Alnylam Pharmaceuticals
ALNY
$58.5B
| $71.5M | 0.89% | 600,000 +150,000 | +33% | +$17.9M |
|
7
Atara Biotherapeutics
ATRA
$84.6M
| $48.8M | 0.61% | 1,250,000 +250,000 | +25% | +$9.75M |
|
|
BPMC
8
DELISTED
Blueprint Medicines
BPMC
| $41.3M | 0.52% | 450,000 +350,000 | +350% | +$32.1M |
|
9
Agios Pharmaceuticals
AGIO
$2.19B
| $40.9M | 0.51% | 500,000 | – | – |
|
|
10
Amicus Therapeutics
FOLD
$2.34B
| $37.6M | 0.47% | 2,500,000 +1,500,000 | +150% | +$22.6M |
|
|
TSRO
11
DELISTED
TESARO, Inc.
TSRO
| $34.3M | 0.43% | 600,000 +500,000 | +500% | +$28.6M |
|
|
XLRN
12
DELISTED
Acceleron Pharma Inc.
XLRN
| $33.2M | 0.42% | 850,000 +100,000 | +13% | +$3.91M |
|
|
ARRY
13
DELISTED
Array Biopharma Inc
ARRY
| $32.6M | 0.41% | 2,000,000 +500,000 | +33% | +$8.16M |
|
|
BLUE
14
DELISTED
bluebird bio
BLUE
| $25.6M | 0.32% | 150,000 | – | – |
|
|
15
Incyte
INCY
$16.5B
| $25M | 0.31% | 300,000 -200,000 | -40% | -$16.7M |
|
16
AnaptysBio
ANAB
$569M
| $19.8M | 0.25% | 190,000 +40,000 | +27% | +$4.16M |
|
|
AVXS
17
DELISTED
AveXis, Inc. Common Stock
AVXS
| $19.8M | 0.25% | 160,000 +10,000 | +7% | +$1.24M |
|
|
ALBO
18
DELISTED
Albireo Pharma, Inc. Common Stock
ALBO
| $17.8M | 0.22% | 547,841 +247,841 | +83% | +$8.07M |
|
|
SAGE
19
DELISTED
Sage Therapeutics
SAGE
| $16.1M | 0.2% | 100,000 +25,000 | +33% | +$4.03M |
|
|
AGEN
20
Agenus
AGEN
$133M
| $13M | 0.16% | 2,750,000 +249,745 | +10% | +$1.18M |
|
21
argenx
ARGX
$43.6B
| $12.1M | 0.15% | 150,000 -50,000 | -25% | -$4.02M |
|
22
iQIYI
IQ
$2.55B
| $11.7M | 0.15% | +750,000 | New | +$11.7M |
|
23
FibroGen
FGEN
$47.8M
| $11.6M | 0.14% | +250,000 | New | +$11.6M |
|
|
AXDX
24
DELISTED
Accelerate Diagnostics
AXDX
| $11.4M | 0.14% | 500,000 | – | – |
|
|
RDUS
25
DELISTED
Radius Health, Inc.
RDUS
| $10.8M | 0.13% | 300,000 -100,000 | -25% | -$3.59M |
|